Your shopping cart is currently empty

Ubiquitin Conjugating Enzyme E2C (EC 2.3.2.24) is a member of the E2 ubiquitin-conjugating enzyme family and serves as a key regulatory factor in the protein degradation pathway in eukaryotes. It is involved in the development and progression of various malignant tumors and plays a role in the degradation of mitotic cycle proteins, thereby impacting cell cycle progression. Additionally, Ubiquitin Conjugating Enzyme E2C acts as a prognostic marker for cholangiocarcinoma.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Ubiquitin Conjugating Enzyme E2C (EC 2.3.2.24) is a member of the E2 ubiquitin-conjugating enzyme family and serves as a key regulatory factor in the protein degradation pathway in eukaryotes. It is involved in the development and progression of various malignant tumors and plays a role in the degradation of mitotic cycle proteins, thereby impacting cell cycle progression. Additionally, Ubiquitin Conjugating Enzyme E2C acts as a prognostic marker for cholangiocarcinoma. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.